Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,214 | 2,105 | 3,606 | 0 | 0 |
| Marketable Securities | 495 | N/A | N/A | 0 | 0 |
| Other current assets | 0 | 493 | 347 | 0 | 0 |
| TOTAL | $21,046 | $2,645 | $3,997 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 344 | 346 | 329 | N/A | N/A |
| Intangibles | 9,667 | 9,833 | 9,999 | 0 | 0 |
| TOTAL | $10,011 | $10,179 | $10,328 | $N/A | $N/A |
| Total Assets | $31,057 | $12,824 | $14,325 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 333 | 296 | 262 | 0 | 0 |
| Accrued Expenses | 257 | 354 | 398 | 0 | 0 |
| TOTAL | $590 | $650 | $660 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $590 | $650 | $660 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,315 | 13,315 | N/A | N/A | N/A |
| Common Shares | 13 | 8 | 8 | 0 | 0 |
| Retained earnings | -7,030 | -4,772 | -3,088 | 0 | 0 |
| TOTAL | $30,467 | $12,174 | $13,665 | $0 | $0 |
| Total Liabilities And Equity | $31,057 | $12,824 | $14,325 | $0 | $0 |